Table 3 Summary of univariate/multivariate analysis for overall survival in patients with NSCLC (n = 350)
Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
Average survival time (SE) | 95%CI | P-value | Exp (B) | 95.0%CI | P-value | |
p-S6 | ||||||
 High expression | 44.561 (3.050) | 38.583-50.540 | 0.013* | 1.549 | 1.105-2.173 | 0.011* |
 Low expression | 67.500 (5.336) | 57.041-77.958 |  |  |  |  |
Clinical stages | ||||||
 Stage I-II | 68.200 (4.195) | 59.977-76.423 | 0.000* | 1.980 | 1.356-2.893 | 0.000* |
 Stage III | 47.862 (3.834) | 40.347-55.378 |  |  |  |  |
LN status | ||||||
 LNM | 44.969 (3.201) | 38.695-51.243 | 0.000* | 1.609 | 1.098-2.360 | 0.015* |
 No LNM | 74.932 (5.919) | 63.330-86.533 |  |  |  |  |
Histological type | ||||||
 SCC | 63.464 (5.825) | 52.046-74.882 | 0.240 | 1.137 | 0.806-1.603 | 0.464 |
 ADC | 50.588 (3.367) | 43.988-57.188 |  |  |  |  |
Pathological grade | ||||||
 Well/moderated | 58.662 (3.509) | 51.784-65.541 | 0.003* | 1.517 | 1.094-2.104 | 0.013* |
 Poor | 54.226 (4.164) | 46.066-62.387 |  |  |  |  |
Age | ||||||
  ≤ 50 | 45.395 (3.633) | 38.274-52.515 | 0.454 | 1.014 | 0.718-1.430 | 0.939 |
 >50 | 61.199 (4.064) | 53.234-69.165 |  |  |  |  |
Gender | ||||||
 Female | 54.566 (4.467) | 45.810-63.321 | 0.210 | 0.718 | 0.484-1.064 | 0.099 |
 Male | 57.363 (3.886) | 49.747-64.978 |  |  |  |  |